Literature DB >> 1538006

Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity.

P Nihoyannopoulos1, G Karatasakis, M Frenneaux, W J McKenna, C M Oakley.   

Abstract

Doppler echocardiography was used to assess diastolic function in 40 patients with hypertrophic cardiomyopathy and to relate it to the patients' symptoms, anaerobic threshold and maximal oxygen consumption during cardiopulmonary exercise testing. The patients had a smaller early (E wave) (p less than 0.01), higher late (A wave) (p less than 0.05) mitral diastolic flow velocity, larger A/E ratio (p less than 0.01), longer isovolumetric relaxation time and E wave duration (p less than 0.001) and slower deceleration rate of the E wave (p less than 0.001) than 40 age- and gender-matched normal subjects. In the patients with hypertrophic cardiomyopathy, maximal oxygen consumption and anaerobic threshold were, respectively, 26.3 +/- 9.2 and 21.1 +/- 6.1 ml/kg per min compared with 47 (range 39 to 68) (p less than 0.01) and 41 (range 27 to 58) ml/kg per min (p less than 0.01) in normal subjects. There was no relation between Doppler indexes and symptoms but symptomatic patients had lower maximal oxygen consumption and anaerobic threshold compared with asymptomatic patients (21.4 +/- 7 vs. 30.7 +/- 10, p less than 0.001 and 18.6 +/- 4.7 vs. 23.1 +/- 5.7, respectively, p less than 0.001). In conclusion, Doppler echocardiography can identify abnormalities of left ventricular filling in patients with hypertrophic cardiomyopathy. However, these indexes measured at rest do not correspond to the patient's professed symptomatic status or exercise capacity measured objectively. Conversely, cardiopulmonary exercise testing reveals a depressed maximal oxygen consumption and anaerobic threshold even in the least symptomatic patients.

Entities:  

Mesh:

Year:  1992        PMID: 1538006     DOI: 10.1016/s0735-1097(10)80268-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  16 in total

1.  Echocardiographic pitfalls in the diagnosis of hypertrophic cardiomyopathy.

Authors:  K Prasad; J Atherton; G C Smith; W J McKenna; M P Frenneaux; P Nihoyannopoulos
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

2.  Clinical significance of N-terminal-probrain natriuretic peptide in hypertrophic cardiomyopathy.

Authors:  Georgios K Efthimiadis; Areti Hitoglou-Makedou; Georgios Giannakoulas; Anastasia Mitakidou; Theodoros Karamitsos; Haralambos Karvounis; Sotirios Mochlas; Ioannis Styliadis; Haris Stefanidis; Georgios Parcharidis; Georgios Louridas
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

3.  Early diastolic function during exertion influences exercise intolerance in patients with hypertrophic cardiomyopathy.

Authors:  Kei Mizukoshi; Kengo Suzuki; Kihei Yoneyama; Ryo Kamijima; Seisyou Kou; Manabu Takai; Masaki Izumo; Akio Hayashi; Eiji Ohtaki; Yoshihiro J Akashi; Naohiko Osada; Kazuto Omiya; Tomoo Harada; Sachihiko Nobuoka; Fumihiko Miyake
Journal:  J Echocardiogr       Date:  2012-10-19

Review 4.  The Muscle-Bound Heart.

Authors:  Marwan M Refaat; Akl C Fahed; Sylvana Hassanieh; Mostafa Hotait; Mariam Arabi; Hadi Skouri; Jonathan G Seidman; Christine E Seidman; Fadi F Bitar; Georges Nemer
Journal:  Card Electrophysiol Clin       Date:  2016-03

5.  Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity.

Authors:  Y Matsumura; P M Elliott; M S Virdee; P Sorajja; Y Doi; W J McKenna
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

6.  Short- and long-term effects of nisoldipine on cardiac function and exercise tolerance in patients with hypertrophic cardiomyopathy.

Authors:  T Tokushima; T Utsunomiya; T Ogawa; K Kidoh; Y Ohtsubo; T Ryu; K Yoshida; T Ogata; S Tsuji; S Matsuo
Journal:  Basic Res Cardiol       Date:  1996 Jul-Aug       Impact factor: 17.165

7.  Effects of hypertrophy and fibrosis on regional and global functional heterogeneity in hypertrophic cardiomyopathy.

Authors:  Sung-A Chang; Sang-Chol Lee; Yeon Hyeon Choe; Hye-Jin Hahn; Shin Yi Jang; Sung-Ji Park; Jin-Oh Choi; Seung Woo Park; Jae K Oh
Journal:  Int J Cardiovasc Imaging       Date:  2012-10-25       Impact factor: 2.357

8.  Left ventricular strain and untwist in hypertrophic cardiomyopathy: relation to exercise capacity.

Authors:  Khalid Abozguia; Ganesh Nallur-Shivu; Thanh T Phan; Ibrar Ahmed; Rajat Kalra; Rebekah A Weaver; William J McKenna; John E Sanderson; Perry Elliott; Michael P Frenneaux
Journal:  Am Heart J       Date:  2010-05       Impact factor: 4.749

9.  Elevated carbohydrate antigen 125 levels in hypertrophic cardiomyopathy patients with heart failure.

Authors:  Ercan Varol; Mehmet Ozaydin; Ahmet Altinbas; Suleyman M Aslan; Abdullah Dogan; Ozkan Dede
Journal:  Heart Vessels       Date:  2007-01-26       Impact factor: 2.037

10.  Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography.

Authors:  J C C Moon; N G Fisher; W J McKenna; D J Pennell
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.